Page last updated: 2024-11-05

troglitazone and Labor, Premature

troglitazone has been researched along with Labor, Premature in 1 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nightingale, SL1

Other Studies

1 other study available for troglitazone and Labor, Premature

ArticleYear
From the Food and Drug Administration.
    JAMA, 1998, Jan-07, Volume: 279, Issue:1

    Topics: Animals; Antioxidants; Chromans; Computer Communication Networks; Drug Labeling; Drug Monitoring; Fe

1998